Our findings also position NUDT5 in the context of nucleotide analogue toxicity, including in cancer, autoinflammatory disorder, and antiviral therapies, a notion supported by other recent reports, notably those identifying germline NUDT5 genetic variants associated with 6-TG resistance in acute lymphoblastic leukaemia79–82. This evidence concerns the gene NUDT5 and cancer.